DAP identified an opportunity to improve patient outcomes in diabetes through individualizing therapy. By facilitating a partnership between an industry leader and leading medical associations, DAP convened a meeting among diabetes thought leaders in epidemiology, and clinical and genetic research, on the topic of individualizing therapy. The meeting stimulated new collaborations in research and a publication summarizing the state of the science and recommendations on how to move practice closer to more effective individualized therapy.

Previous  |  Improving Patient Care  |  Next